Abstract
Background
In the last decades, a higher incidence of congenital hypothyroidism (CH) has been recorded in Italy (1:1940) and worldwide, mainly due to the shift to lower screening TSH cutoffs. Although CH can also be caused by dysgenetic defects, most CH cases have recently been found to be more frequently associated with functional defects of an in situ thyroid gland. Although the clinical phenotype is milder with high prevalence of transient forms, some cases eventually prove to be permanent.
Results
Possible explanations of the raised incidence of CH are ethnic modifications of the screened population and the increasing incidence of preterm birth and multiple pregnancies. These findings are important in terms of public health and standardization of screening programmes for special at-risk categories such as preterms, acutely ill term neonates, low birth weight and very low birth weight infants, and newborns with specific drug exposure. Other environmental factors have contributed to the increased incidence of hypothyroidism, including thyroid disrupting chemicals, iodine supply (excess/deficiency), and drugs interfering with thyroid function. Finally, an increased prevalence of hypothyroidism has been documented in obese children and patients with syndromic forms (Williams, Down, Turner, pseudohypoparathyroidism). The clinical and molecular phenotype of patients with CH will be better defined thanks to novel genetic approach based on the systematic analysis of a panel of genes (TSHR, DUOX2, DUOXA, TPO, PDS, TG, NKX2.1, JAG1, GLIS3, FOXE1, PAX-8).
Conclusions
This review summarizes significant advances in the epidemiology and aetiology of non-autoimmune hypothyroidism, with a focus on thyroid dysfunction in preterm infants.
Similar content being viewed by others
References
Léger J, Olivieri A, Donaldson M et al (2014) European society for paediatric endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. J Clin Endocrinol Metab 99(2):363–384
Lanting CI, van Tijn DA, Loeber JG et al (2005) Clinical effectiveness and cost-effectiveness of the use of the thyroxine/thyroxine-binding globulin ratio to detect congenital hypothyroidism of thyroidal and central origin in a neonatal screening program. Pediatrics 116(1):168–173
Tajima T, Nakamura A, Morikawa S et al (2014) Neonatal screening and a new cause of congenital central hypothyroidism. Ann Pediatr Endocrinol Metab 19:117–121
Zwaveling-Soonawala N, van Trotsenburg P, Verkerk H et al (2015) The severity of congenital hypothyroidism of central origin should not be underestimated. J Clin Endocrinol Metab 100(2):E297–E300
Tajima T, Ishizu K, Nakamura A (2013) Molecular and clinical findings in patients with LHX4 and OTX2 mutations. Clin Pediatr Endocrinol 22(2):15–23
Szinnai G (2014) Clinical genetics of congenital hypothyroidism. Endocr Dev 26:60–78
Persani L, Calebiro D, Cordella D et al (2010) Genetics and phenomics of hypothyroidism due to TSH resistance. Mol Cell Endocrinol 322(1–2):72–82
Tenenbaum-Rakover Y, Almashanu S, Hess O et al (2015) Long-term outcome of loss-of-function mutations in TSH receptor gene. Thyroid 25:292–299
Calebiro D, Gelmini G, Cordella D et al (2012) Frequent TSH receptor genetic alterations with variable signaling impairment in a large series of children with nonautoimmune isolated hyperthyrotropinemia. J Clin Endocrinol Metab 97:E156–E160
Nicoletti A, Bal M, De Marco G et al (2009) Thyrotropin-stimulating hormone gene analysis in pediatric patients with non-autoimmune subclinical hypothyroidism. J Clin Endocrinol Metab 94:4187–4194
Vigone MC, Fugazzola L, Zamproni I et al (2005) Persistent mild hypothyroidism associated with novel sequence variants of the DUOX2 gene in two siblings. Hum Mutat 26(4):395
Muzza M, Rabbiosi S, Vigone MC et al (2014) The clinical and molecular characterization of patients with dyshormonogenic congenital hypothyroidism reveals specific diagnostic clues for DUOX2 defects. J Clin Endocrinol Metab 99(3):E544–E553
Dussault JH (1999) The anecdotal history of screening for congenital hypothyroidism. J Clin Endocrinol Metab 84(12):4332–4334
Rastogi MV, LaFranchi SH (2010) Congenital hypothyroidism. Orphanet J Rare Dis 5:17
Wassner AJ, Brown RS (2013) Hypothyroidism in the newborn period. Curr Opin Endocrinol Diabetes Obes 20(5):449–454
Olivieri A, Fazzini C, Medda E (2015) Multiple factors influencing the incidence of congenital hypothyroidism detected by neonatal screening. Horm Res Paediatr 83:86–93
Corbetta C, Weber G, Cortinovis F et al (2009) A 7-year experience with low blood TSH cutoff levels for neonatal screening reveals an unsuspected frequency of congenital hypothyroidism (CH). Clin Endocrinol (Oxf) 71(5):739–745
Mengreli C, Kanaka-Gantenbein C, Girginoudis P et al (2010) Screening for congenital hypothyroidism: the significance of threshold limit in false-negative results. J Clin Endocrinol Metab 95(9):4283–4290
Deladoëy J, Ruel J, Giguère Y, Van Vliet G (2011) Is the incidence of congenital hypothyroidism really increasing? A 20-year retrospective population-based study in Québec. J Clin Endocrinol Metab 96(8):2422–2429
Olivieri A, Corbetta C, Weber G et al (2013) Congenital hypothyroidism due to defects of thyroid development and mild increase of TSH at screening: data from the Italian National Registry of infants with congenital hypothyroidism. J Clin Endocrinol Metab 98(4):1403–1408
Rabbiosi S, Vigone MC, Cortinovis F et al (2013) Congenital hypothyroidism with eutopic thyroid gland: analysis of clinical and biochemical features at diagnosis and after re-evaluation. J Clin Endocrinol Metab 98(4):1395–1402
Hinton CF, Harris KB, Borgfeld L et al (2010) Trends in incidence rates of congenital hypothyroidism related to select demographic factors: data from the United States, California, Massachusetts, New York, and Texas. Pediatrics 125(Suppl 2):S37–S47
Beck S, Wojdyla D, Say L et al (2010) The worldwide incidence of preterm: a systematic review of maternal birth mortality and morbidity. Bull World Health Organ 88:31–38
Vigone MC, Caiulo S, Di Frenna M et al (2014) Evolution of thyroid function in preterm infants detected by screening for congenital hypothyroidism. J Pediatr 164(6):1296–1302
Radetti G, Fanolla A, Pappalardo L et al (2007) Prematurity may be a risk factor for thyroid dysfunction in childhood. J Clin Endocrinol Metab 92(1):155–159
Ares S, Quero J, de Escobar GM (2008) Iodine balance, iatrogenic excess, and thyroid dysfunction in premature newborns. Semin Perinatol 32(6):407–412
Cassio A, Corbetta C, Antonozzi I et al (2013) The Italian screening program for primary congenital hypothyroidism: actions to improve screening, diagnosis, follow-up, and surveillance. J Endocrinol Invest 36(3):195–203
LaFranchi SH (2010) Newborn screening strategies for congenital hypothyroidism: an update. J Inherit Metab Dis 33(Suppl 2):S225–S233
Goldsmit GS, Valdes M, Herzovich V et al (2011) Evaluation and clinical application of changes in thyroid hormone and TSH levels in critically ill full-term newborns. J Perinat Med 39(1):59–64
Olivieri A, Stazi MA, Mastroiacovo P et al (2002) A population-based study on the frequency of additional congenital malformations in infants with congenital hypothyroidism: data from the Italian Registry for Congenital Hypothyroidism (1991–1998). J Clin Endocrinol Metab 87(2):557–562
Olivieri A, Medda E, De Angelis S et al (2007) High risk of congenital hypothyroidism in multiple pregnancies. J Clin Endocrinol Metab 92(8):3141–3147
Filippi L, Pezzati M, Poggi C et al (2007) Dopamine versus dobutamine in very low birthweight infants: endocrine effects. Arch Dis Child Fetal Neonatal Ed 92(5):F367–F371
Olivieri A (2012) Epidemiology of congenital hypothyroidism: what can be deduced from the Italian registry of infants with congenital hypothyroidism. J Matern Fetal Neonatal Med 25(Suppl 5):7–9
Reynolds MA, Schieve LA, Martin JA et al (2003) Trends in multiple births conceived using assisted reproductive technology, United States, 1997–2000. Pediatrics 111(5 Pt 2):1159–1162
Sakka SD, Malamitsi-Puchner A, Loutradis D (2009) Euthyroid hyperthyrotropinemia in children born after in vitro fertilization. J Clin Endocrinol Metab 94(4):1338–1341
Zimmermann MB (2013) Iodine deficiency and excess in children: worldwide status in 2013. Endocr Pract 19(5):839–846
Global Iodine Nutrition Scorecard (2014) Available at: http//www.ign.org/cm_data/Scorecard_IGN_website_02_03_2015.pdf. Accessed 23 March 2015
Harris KB, Pass KA (2007) Increase in congenital hypothyroidism in New York State and in the United States. Mol Genet Metab 91(3):268–277
Belfort MB, Pearce EN, Braverman LE et al (2012) Low iodine content in the diets of hospitalized preterm infants. J Clin Endocrinol Metab 97(4):E632–E636
Andra SS, Makris K (2012) Thyroid disrupting chemicals in plastic additives and thyroid health. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 30(2):107–151
Chevrier J, Warner M, Gunier RB et al (2014) Serum dioxin concentrations and thyroid hormone levels in the Seveso Women’s Health Study. Am J Epidemiol 180(5):490–498
Baccarelli A, Giacomini SM, Corbetta C et al (2008) Neonatal thyroid function in Seveso 25 years after maternal exposure to dioxin. PLoS Med 5(7):e161
Williams FL, Ogston SA, van Toor H et al (2005) Serum thyroid hormones in preterm infants: associations with postnatal illnesses and drug usage. J Clin Endocrinol Metab 90(11):5954–5963
Knudsen N, Laurberg P, Rasmussen LB et al (2005) Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab 90(7):4019–4024
Reinehr T (2010) Obesity and thyroid function. Mol Cell Endocrinol 316(2):165–171
Selicorni A, Fratoni A, Pavesi MA et al (2006) Thyroid anomalies in Williams syndrome: investigation of 95 patients. Am J Med Genet A 140(10):1098–1101
Stagi S, Bindi G, Neri AS et al (2005) Thyroid function and morphology in patients affected by Williams syndrome. Clin Endocrinol (Oxf) 63(4):456–460
Cherniske EM, Carpenter TO, Klaiman C et al (2004) Multisystem study of 20 older adults with Williams syndrome. Am J Med Genet A 131(3):255–264
Claret C, Goday A, Benaiges D et al (2013) Subclinical hypothyroidism in the first years of life in patients with Down syndrome. Pediatr Res 73(5):674–678
Jørgensen KT, Rostgaard K, Bache I et al (2010) Autoimmune diseases in women with Turner’s syndrome. Arthritis Rheum 62(3):658–666
Grossi A, Crinò A, Luciano R et al (2013) Endocrine autoimmunity in Turner syndrome. Ital J Pediatr 39:79
Huang SA, Tu HM, Harney JW et al (2000) Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med 343(3):185–189
Vigone MC, Cortinovis F, Rabbiosi S et al (2012) Difficult treatment of consumptive hypothyroidism in a child with massive parotid hemangioma. J Pediatr Endocr Met 25(1–2):153–155
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
For this type of study, informed consent is not required.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vigone, M.C., Di Frenna, M. & Weber, G. Heterogeneous phenotype in children affected by non-autoimmune hypothyroidism: an update. J Endocrinol Invest 38, 835–840 (2015). https://doi.org/10.1007/s40618-015-0288-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-015-0288-5